Skip to main content

Table 1 EPCs biosignatures of Ado-treatment response.

From: Predictive integration of gene functional similarity and co-expression defines treatment response of endothelial progenitor cells

Name

Biosignature gene composition

BS

AUC

k

EDQ

Expert-driven queries: CXCR4, CXCL2, CXCL5, CXCL12, CCL7, CCL2, CCL23

7

0.75

-

EDQ+15NN

Expert-driven queries (CXCR4, CXCL2, CXCL5, CXCL12, CCL7, CCL2) together with their most functionally similar genes from integrated k NN strategy*

6

0.92

15

DE

Top-4 data-driven queries:

EFNA1, SH3BP5, PEA15, B2M

4

0.75

-

DE+4NN

Top-4 data-driven queries together with their most functionally similar gene from integrated k NN strategy*

4

0.83

4

EDQ+PPI

Expert-driven queries (CXCR4, CXCL2, CXCL5, CXCL12, CCL7, CCL2) together with their interacting partners in the PPI network

6

0.67

-

  1. Top classification performances (summarized with AUC values) obtained from different query-driven schemes and the integrated k NN. AUC values estimated through LOOCV and correspond to SVM classification models (see Methods). Prediction models based on biosignatures identified by standard statistical techniques or query-driven inputs only are also included (models indicated with " - "). "*": In EDQ+15NN, GO-based similarity in integrated k NN model was estimated with BP terms, in DE+4NN with MF terms. BS: Biosignature size defined as the number of inputs to prediction models based on two schemes: individual gene (EDQ and DE models) and integrated gene neighborhood input representations.